Markets
VTR

Company News for June 03, 2014 - Corporate Summary

A generic image of a person pointing to something on a tablet
Credit: Shutterstock photo

• Shares of CONN'S, Inc. (NASDAQ: CONN ) gained 6.9% after posting first quarter adjusted earnings per share of $0.80, beating the Zacks Consensus Estimate of $0.73

• American Realty Capital Healthcare Trust, Inc.'s (NASDAQ: HCT ) shares climbed 9.7% following news that Ventas, Inc. (NYSE: VTR ) will acquire it for $2.6 billion

• Shares of Allergan, Inc. (NYSE: AGN ) rose 2.9% on news that Valeant Pharmaceuticals International Inc. (NYSE: VRX ) has increased its bid for Allergan from $49.4 billion to $55 billion

• Shares of Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA ) rallied 7.4% after announcing that its trial of Iclusig drug for treating gastrointestinal tumors has shown positive results among some patients

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CONNS INC (CONN): Free Stock Analysis Report

VENTAS INC (VTR): Free Stock Analysis Report

ALLERGAN INC (AGN): Free Stock Analysis Report

VALEANT PHARMA (VRX): Free Stock Analysis Report

ARIAD PHARMA (ARIA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

VTR CONN

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More